Stop TB Partnership

Selection Criteria, Committee, and Ceremony

Selection Criteria

  • A nominee's contribution to TB research in diagnostics, drugs or vaccines.
  • The potential impact of the research on reaching the targets set forth in the Global Plan to End TB and the End TB Strategy
  • Extent to which the Kochon Prize will contribute to furthering the nominee's work in TB research.

Selection Committee is composed of:

Mr Timur Abdullaev
Stop TB Partnership Board Member

Dr Kenneth Castro
Clinical Assistant Professor, Emory University School of Public Health
United States of America

Dr Paula Fujiwara
Scientific Director, International Union Against Tuberculosis and Lung Disease

Mr. Woo Young Soo
Executive Director, Kochon Foundation
Republic of Korea

Dr Mel Spigelman
President and CEO, Global Alliance for TB Drug Development
Co-Chair, Working Group on New TB Drugs
United States of America

Award Announcement and Ceremony

The 2017 Kochon Prize will be announced and awarded during the Stop TB Partnership's 30th Board meeting in March 2018. It will be held in New Delhi, India.

Detailed information will be made available in 2018.